Inhibition of NLRP3 in murine model of arthritis reduced the production of interleukin IL-1β and reduced inflammation of joints (136) and human patients with active RA showed higher expression and activation of NLRP3 (137). This evidence concerns the gene NLRP3 and arthritic joint disease.